Euro-Phospholipid on Line Official Web-site of the "European Forum on Antiphospholipid Antibodies"

V MEETING OF THE EUROPEAN FORUM 
ON ANTIPHOSPHOLIPID ANTIBODIES
Barcelona, 2-3 December 2005
Organizers: Ricard Cervera and Josep Font

---

VENUE: Casa de la Convalescència,

Hospital de Sant Pau, Barcelona

http://www.fundaciouab.com/casa/ENG/casa.html

FRIDAY, 2 DECEMBER

09:00 – 10:00	OPENING CEREMONY Chairpersons: R Cervera, J Font
09:00 – 09:15	Welcome and Meeting Remarks A. Tincani, R. Cervera, J. Font
09:15 – 09:30	Opening Lecture: Tuesday Morning G.R.V. Hughes
09:30 – 09:45	Opening Survey: European Forum on Antiphospholipid Antibodies after 10 years: Realisations and Expectations M-C Boffa
09:45 – 10:00	Opening Survey: Updated criteria for the classification of the APS (Sydney modifications): Where do we stand? R. Cervera

10:00 – 11:00	LABORATORY STANDARDISATION - I Chairpersons: A.Tincani, J.C. Reverter
10:00 – 10:15	State of the Art Overview: Why do we still need standardisation consensus? A.Tincani, F Malacarne, F Allegri, G Balestrieri, PL Meroni, M. Sanmarco, G. Reber, M.C.Boffa.
10:15 – 10:25	Eppur si muove (galileo galilei): the sandardization project with the diagnostic companies. P.L. Meroni, C. Cruini, F. Pregnolato, F. Malacarne, A.Tincani
10:25 – 10:35	aCL standardisation K. Rawson, D. Kewley
10:35 – 10:40	Discussion
10:40 – 10:55	Quantitative LA tests and their application on plasma samples from the WAPS study E.M. Jacobsen, M. Galli, G. Borrelli, F.G.B. Wisloff
10:55 – 11:00	Discussion
11:00 – 11:30	COFFEE BREAK

11:30 – 13:15	LABORATORY STANDARDISATION - II Chairpersons: M. Sanmarco, G. Reber
11:30 – 11:45	A multicentre trial on the predictive value of a β-2-GPI specific LA assay P. de Groot, J. Musial, G. Reber, R. Forastiero, V. Regnault, T. Lecompte, B. Woodhams, P.van Dreden, B. de Laat, R. Derksen
11:45 – 11:50	Discussion
11:50 – 12:05	Factors that influence the results of anti-β-2-GPI ELISAs G. Reber, A. Cavazzana, P. de Moerloose
12:05 – 12:10	Comments by: P. de Groot
12:10 – 12:15	Discussion
12:15 – 12:30	Avidity of anti-β-2-GPI antibodies in patients with APS B. Borut, C. Sasa, A. Ambrozic, T. Kveder, B. Rozman
12:30 – 12:40	Binding of β-2-GPI and other phospholipid cofactor proteins to phospholipids: Role of calcium and of antibodies J. Amiral, A.M. Vissac
12:40 – 12:45	Comments by: A. Tincani
12:45 – 12:50	Comments by: M. Sanmarco
12:50 – 12:55	Discussion
12:55 – 13:10	Proposal of a project on standardisation of an ELISA for the detection of anti-phosphatidylethanolamine antibodies M. Sanmarco, G. Reber, N. Bardin, M-C Boffa
13:10 – 13:15	Discussion

13:15 – 14:45

LUNCH

14:45 – 15:45	BASIC RESEARCH - I Chairpersons: P.L. Meroni, G.Espinosa
14:45 – 15:00	Soluble CD40 ligand in patients with aPL D. Ferro, L. Loffredo, F. Violi, G. Valesini
15:00 – 15:05	Discussion
15:05 – 15:20	Thrombin potential with an Active protein C dynamic Inhibitory system: is it associated with the risk of venous and arterial Thrombosis in SLE or primary APS? – Two case-control studies (TACT and TACIT) D. Wahl, V. Regnault
15:20 – 15:25	Discussion
15:25 – 15:40	The anti-phospholipid tissue targeting in APS: The CNS and kidney involvements M. Blank, P.L. Meroni, R. Cervera, J. Font, J. Sloway, S. Jacobsen, Y Shoenfeld.
15:40 – 15:45	Discussion

15:45 – 16:15

COFFEE / TEA BREAK

16:15 – 17:10	BASIC RESEARCH – II Chairpersons: P. de Groot, M. Blank
16:15 – 16:30	The role of Fc-γRIIa polymorphisms in SLE, APS and catastrophic APS M. Herrmann, U.S. Gaipl, A. Sheriff, J. R. Kalden
16:30 – 16:45	Genetics of APS: The Fc-γRIIa polymorphisms and beyond J. Damoiseaux, R. Theunissen, J.M. Matoso Ferreira, M. Baleva, M. Nikolova, P. van Paassen, J.W. Cohen Tervaert
16:45 – 16:50	Discussion
16:50 – 17:05	The role of annexin V in the modulation of the immune response U.S. Gaipl, M. Hermann, E. Poschl, F. Pausch, A. Sheriff, J.R. Kalden
17:05 – 17:10	Discussion

17:10 – 18:00	FORUM GENERAL ORGANIZATION Chairpersons: A. Tincani, M-C Boffa
	Creation of an Association, Rules, Board, Web-site and Future Meeting City J.C. Piette, P.L. Meroni, R. Derksen, P. De Groot, H. Cohen, S. Machin, R. Cervera, J. Font

21:00 – 23:00

DINNER Can Travi Nou (Prize included in the registration, but CONFIRMATION OF ASSISTANCE REQUIRED) http://www.gruptravi.com/english/principal.asp?rest=travi

SATURDAY, 3 DECEMBER

09:00 – 10:10	OBSTETRIC/PEDIATRIC RESEARCH - I Chairpersons: L. Regan, J. Balasch
09:00 – 09:30	State of the Art Overview: The “obstetric” antiphospholipid syndrome J. Balasch, F. Carmona
09:30 – 09:45	Long term health implications of primary APS in women presenting with recurrent miscarriage – a prospective longitudinal study. P. Jindal, M. Backos, W. Lo, R. Rai, L. Regan
09:45 – 09:50	Discussion
09:50 – 10:05	Register of babies born to mothers with APS E. Lachassine, M.H. Aurousseau, L. Carbillon, O. Fain, C. Biasini-Rebaioli, M. Motta M, A. Lojacono, S. De Carolis, A. Botta, S. Derenne, C. Boinot, N. Schlegel, T. Avcin, P. Le Toumelin, P, Nicaise, J-C Piette, A. Tincani, M. Uzan, M-C Boffa
10:05 – 10:10	Discussion
10:10 – 10:25	Register for pediatric patients with APS T. Avcin, R. Cimaz, R. Cervera, A. Ravelli, A. Martini, B. Rozman, P.L. Meroni
10:25 – 10:30	Discussion

10:30 – 11:00

COFFEE BREAK

11:00 – 11:40	OBSTETRIC/PEDIATRIC RESEARCH - II Chairpersons: M. Motta, F. Carmona
11:00 – 11:15	Register of infants with fetal or perinatal thrombosis born to mothers having aPL: A proposal M.C. Boffa, E. Lachassinne, T. Avcin, M.H. Aurousseau, O. Fain, R. Rai, U. Wollina, P. Mensah, P. Douard, D. Farge-Bancel, R. Cervera, J-C Piette, M. Uzan, L. Regan
11:15 – 11:20	Discussion
11:20 – 11:35	Brain neurosonography in infants from mothers with positive aPL autoimmune disease M. Motta, A. Angeli, M.L. Cardone, A. Tincani, A. Lojacono, G. Chirico
11:35 – 11:40	Discussion
11:40 – 12:40	CLINICAL/EPIDEMIOLOGICAL RESEARCH - I Chairpersons: J-C Piette, J Font
11:40 – 12:00	State of the Art Overview: Significance of livedo reticularis in APS J.C. Piette
12:00 – 12:15	Europhospholipid Project R Cervera, J. Font, J-C Piette, M-C Boffa, M.A. Khamashta, G.R.V. Hughes
12:15 – 12:20	Discussion
12:20 – 12:35	Primary thromboprophylaxis of aPL-positive subjects (ALIWAPAS trial) M.A. Khamashta
12:35 – 12:40	Discussion

12:40 – 14:00

LUNCH

14:00 – 15:10	CLINICAL/EPIDEMIOLOGICAL RESEARCH - II Chairpersons: Y. Shoenfeld, R. Derksen
14:00 – 14:30	State of the Art Overview: APS: From a systemic disease toward the infectious etiology Y. Shoenfeld
14:30 – 14:45	The catastrophic APS (CAPS) Registry (European-extended project) R. Cervera, J-C Piette, Y. Shoenfeld, J. Font, S. Bucciarelli, R. Asherson
14:45 – 14:50	Discussion
14:50 – 15:05	aPL, infections and autoimmune diseases Y. Sherer, M. Blank, R. Cervera, A.G. Tzioufas, A. Doria, L. Guillevin, R. Gerli, M. Matucci-Cerinic, S. Bombardieri, I. Lundberg, A. Tincani, A. Achiron, J. Chapman, C. Selmi, S. Jacobsen, L. Stojanovich, G. Valentini, B. Rozman, T. Kveder, S. Praprotnic, J. Martín, P. Youinou, J.M. Anaya, G. Godard, Y. Chovers,Y. Shoenfeld
15:05 – 15:10	Discussion

15:10 – 15:40

COFFEE / TEA BREAK

15:40 – 16:40	CLINICAL/EPIDEMIOLOGICAL RESEARCH - III Chairpersons: M.A. Khamashta, M. Ramos-Casals
15:40 – 15:55	Follow-up investigation of patients with ischemic cerebral manifestations of the APS: Predictive value of high-sensitive C-reactive protein (hs-CRP) W. Miesbach, D. Claus, I. Scharrer, A. Gilzinger, B. Gokpinar, G. Asmelash, B. Putz, T. Vigh
15:55 – 16:00	Discussion
16:00 – 16:15	Presence of atherosclerosis in patients with primary APS, secondary APS and SLE – A comparative study. M. Meissner, H. Chwalinska-Sadowska, B. Wojciechowska, J. Zabek, G. Malek, W. Tomkowski
16:15 – 16:20	Discussion
16:20 – 16:35	Multiple positivity of aPL and the risk of clinical events in patients with autoimmune diseases J. Swadzba, T. Iwaniec, J. Musial
16:35 – 16:40	Discussion
16:40 – 17:00	Last minute talks

17:00 – 17:15

CONCLUSIONS AND FUTURE A Tincani, M.C. Boffa, R. Cervera

For additional information and applications, please e-mail: rcervera@clinic.ub.es

---

Web contens: EWPSLE Info Desk.

Last updated: 30 November 2005